Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Circ Res ; 113(5): 617-31, 2013 Aug 16.
Article in English | MEDLINE | ID: mdl-23948586

ABSTRACT

In the heart, adrenergic stimulation activates the ß-adrenergic receptors coupled to the heterotrimeric stimulatory Gs protein, followed by subsequent activation of adenylyl cyclase, elevation of cyclic AMP levels, and protein kinase A (PKA) activation. One of the main targets for PKA modulation is the cardiac L-type Ca²âº channel (CaV1.2) located in the plasma membrane and along the T-tubules, which mediates Ca²âº entry into cardiomyocytes. ß-Adrenergic receptor activation increases the Ca²âº current via CaV1.2 channels and is responsible for the positive ionotropic effect of adrenergic stimulation. Despite decades of research, the molecular mechanism underlying this modulation has not been fully resolved. On the contrary, initial reports of identification of key components in this modulation were later refuted using advanced model systems, especially transgenic animals. Some of the cardinal debated issues include details of specific subunits and residues in CaV1.2 phosphorylated by PKA, the nature, extent, and role of post-translational processing of CaV1.2, and the role of auxiliary proteins (such as A kinase anchoring proteins) involved in PKA regulation. In addition, the previously proposed crucial role of PKA in modulation of unstimulated Ca²âº current in the absence of ß-adrenergic receptor stimulation and in voltage-dependent facilitation of CaV1.2 remains uncertain. Full reconstitution of the ß-adrenergic receptor signaling pathway in heterologous expression systems remains an unmet challenge. This review summarizes the past and new findings, the mechanisms proposed and later proven, rejected or disputed, and emphasizes the essential issues that remain unresolved.


Subject(s)
Calcium Channels, L-Type/physiology , Models, Cardiovascular , Myocytes, Cardiac/metabolism , Receptors, Adrenergic, beta/physiology , A Kinase Anchor Proteins/physiology , Adrenergic beta-Agonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Animals , Calcium/metabolism , Cardiotonic Agents/pharmacology , Cyclic AMP/physiology , Cyclic AMP-Dependent Protein Kinases/physiology , Humans , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Protein Processing, Post-Translational , Protein Subunits , Second Messenger Systems/physiology
2.
J Biol Chem ; 288(18): 12680-91, 2013 May 03.
Article in English | MEDLINE | ID: mdl-23530039

ABSTRACT

CaV1.2 interacts with the Ca(2+) sensor proteins, calmodulin (CaM) and calcium-binding protein 1 (CaBP1), via multiple, partially overlapping sites in the main subunit of CaV1.2, α1C. Ca(2+)/CaM mediates a negative feedback regulation of Cav1.2 by incoming Ca(2+) ions (Ca(2+)-dependent inactivation (CDI)). CaBP1 eliminates this action of CaM through a poorly understood mechanism. We examined the hypothesis that CaBP1 acts by competing with CaM for common interaction sites in the α1C- subunit using Förster resonance energy transfer (FRET) and recording of Cav1.2 currents in Xenopus oocytes. FRET detected interactions between fluorescently labeled CaM or CaBP1 with the membrane-attached proximal C terminus (pCT) and the N terminus (NT) of α1C. However, mutual overexpression of CaM and CaBP1 proved inadequate to quantitatively assess competition between these proteins for α1C. Therefore, we utilized titrated injection of purified CaM and CaBP1 to analyze their mutual effects. CaM reduced FRET between CaBP1 and pCT, but not NT, suggesting competition between CaBP1 and CaM for pCT only. Titrated injection of CaBP1 and CaM altered the kinetics of CDI, allowing analysis of their opposite regulation of CaV1.2. The CaBP1-induced slowing of CDI was largely eliminated by CaM, corroborating a competition mechanism, but 15-20% of the effect of CaBP1 was CaM-resistant. Both components of CaBP1 action were present in a truncated α1C where N-terminal CaM- and CaBP1-binding sites have been deleted, suggesting that the NT is not essential for the functional effects of CaBP1. We propose that CaBP1 acts via interaction(s) with the pCT and possibly additional sites in α1C.


Subject(s)
Calcium Channels, L-Type/metabolism , Calcium-Binding Proteins/metabolism , Calmodulin/metabolism , Ion Channel Gating/physiology , Oocytes/metabolism , Xenopus Proteins/metabolism , Animals , Calcium Channels, L-Type/genetics , Calcium-Binding Proteins/genetics , Calmodulin/genetics , Fluorescence Resonance Energy Transfer , Kinetics , Oocytes/cytology , Xenopus Proteins/genetics , Xenopus laevis
3.
Channels (Austin) ; 3(5): 337-42, 2009.
Article in English | MEDLINE | ID: mdl-19713738

ABSTRACT

Interaction of calmodulin (CaM) with the C-terminus (CT) of the L-type Ca(V)1.2 channel is crucial for Ca(2+)-dependent inactivation (CDI). CaM also binds to the N-terminus (NT), and a CaM-formed "bridge" between CT and NT has been proposed to control CDI. We characterized the interaction of CaM with its NT-binding peptide. Binding is Ca(2+)-dependent with an affinity of 0.6 microM. Mutations in NT of Ca(V)1.2 that abolished the binding of CaM only slightly weakened the CDI but also accelerated the VDI. CaM did not foster an interaction between the CaM-binding peptides of NT and CT. Thus, the role of CaM's interaction with the Ca(V)1.2 NT remains to be determined.


Subject(s)
Calcium Channels, L-Type/chemistry , Calmodulin/chemistry , Amino Acid Sequence , Animals , Binding Sites , Dose-Response Relationship, Drug , Female , Glutathione Transferase , Humans , Molecular Sequence Data , Mutation , Oocytes/cytology , Peptides/chemistry , Protein Binding , Protein Structure, Tertiary , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...